Using both the Fraction and Quantity of Donor-Derived Cell-Free DNA to Detect Kidney Allograft Rejection

Suphamai Bunnapradist; Piyavadee Homkrailas; Ebad Ahmed; Gordon Fehringer; Paul R Billings; Hossein Tabriziani

doi:10.1681/ASN.2021050645

Using both the Fraction and Quantity of Donor-Derived Cell-Free DNA to Detect Kidney Allograft Rejection

J Am Soc Nephrol. 2021 Oct;32(10):2439-2441. doi: 10.1681/ASN.2021050645. Epub 2021 Jun 23.

Authors

Suphamai Bunnapradist¹, Piyavadee Homkrailas¹, Ebad Ahmed², Gordon Fehringer³, Paul R Billings³, Hossein Tabriziani³

Affiliations

¹ Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California.
² R&D, Natera, Inc., San Carlos, California.
³ Medical Affairs, Natera, Inc., San Carlos, California.

No abstract available

Keywords: acute allograft rejection; acute rejection; allografts; cell-free nucleic acids; chronic allograft rejection; kidney; kidney biopsy; transplantation.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Algorithms
Allografts
Biomarkers / blood
Biopsy
Cell-Free Nucleic Acids / blood*
Graft Rejection / blood*
Graft Rejection / diagnosis*
Graft Rejection / pathology
Humans
Kidney / pathology
Sensitivity and Specificity
Tissue Donors

Substances

Biomarkers
Cell-Free Nucleic Acids